Figure 2.
Clinical and histological response of subject in phase II study of adalimumab after 12 weeks. Clinical photos target lesion at day 0 (A) and day 84 (B) and representative histological specimens at day 0 (C) and day 84 (D).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.